Motor Performance Improvement After Visual Rehabilitation
Launched by INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN · Nov 18, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a program called Visionary VR can improve motor performance and visual function in adults who have experienced an acquired brain injury, which can result from a stroke or trauma. The study aims to help individuals with visual field loss—meaning they have difficulty seeing in certain parts of their vision—by using tools like special lenses, prisms, and virtual reality exercises. The goal is to enhance their balance, mobility, and overall ability to perform daily activities.
To participate in the trial, you must be an adult aged 18 to 75 who has suffered an acquired brain injury more than six months ago and does not have cognitive impairments or significant eye issues like glaucoma. You'll need access to a computer and the internet to do exercises at home. If you join, you can expect to engage in a variety of rehabilitation activities designed to stimulate your vision and improve your motor skills, all while being guided by a team of professionals. This study is currently recruiting participants, so it's a great opportunity to contribute to new treatment methods for visual rehabilitation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult subjects diagnosed with acquired brain injury either from a stroke or trauma.
- • Subjects without cognitive impairment.
- • Subjects without pre-existing musculoskeletal disorders prior to the acquired brain injury.
- • Subjects without hemineglect.
- • Subjects with more than 6 months of progression since the brain injury.
- • Subjects who have an electronic device such as a computer and internet access to perform the exercises at home.
- • Subjects with altitudinal visual field loss, hemianopia, or quadrantanopia with the central field preserved and at least 0.5 visual acuity.
- Exclusion Criteria:
- • Not signing the informed consent.
- • Previous severe mental pathology to eliminate possible confounding factors if their daily activities are already affected.
- • Uncontrolled epilepsy.
- • Subjects with glaucoma or retinal pathologies affecting the visual field.
- • Subjects with previous ocular surgery (cataract or refractive surgery) with less than 6 months of progression.
- • Subjects who are not stable in any associated clinical pathology or otherwise diagnosed.
- • Subjects who have previously undergone visual rehabilitation for the field defect.
- • Not performing the proposed home exercises.
About Instituto De Investigación Sanitaria Aragón
Instituto de Investigación Sanitaria Aragón (IIS Aragón) is a leading clinical research organization dedicated to advancing healthcare through innovative research and collaboration. Based in Spain, IIS Aragón focuses on translational medicine, bridging the gap between laboratory discoveries and clinical applications. The institute fosters a multidisciplinary approach, bringing together experts from various fields to enhance the quality and efficiency of clinical trials. With a commitment to ethical standards and patient safety, IIS Aragón plays a pivotal role in driving scientific advancements and improving health outcomes in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zaragoza, , Spain
Patients applied
Trial Officials
Maria José López de la Fuente, PhD
Study Chair
Universidad de Zaragoza
Jorge Pérez Rey, PhD
Study Chair
Universidad de Zaragoza
Naiara Díaz Marín, MSc
Study Chair
Universidad de Zaragoza
Javier Mateo Gabás, PhD
Study Chair
Universidad de Zaragoza
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported